Carr Financial Group Corp Novartis Ag Transaction History
Carr Financial Group Corp
- $364 Billion
- Q3 2025
A detailed history of Carr Financial Group Corp transactions in Novartis Ag stock. As of the latest transaction made, Carr Financial Group Corp holds 2,923 shares of NVS stock, worth $384,520. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,923
Previous 2,923
-0.0%
Holding current value
$384,520
Previous $354 Million
5.97%
% of portfolio
0.1%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,603Shares Held
137MCall Options Held
1.55MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...